The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A)
Authors:
- I C SturdgessISI C Sturdgess
- A J MolyneuxAMA J Molyneux
Open Access
- 1 March 2001
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 54 (3) , 196-200
Abstract
Aim —To compare the sensitivity and staining pattern of the new immunohistochemical antibody to tyrosinase (T311) with S-100, HMB45, and the recently evaluated antibody to melan-A (A103) in a range of melanocytic lesions. Method —Archival, formalin fixed, paraffin wax embedded sections from 50 benign and malignant melanocytic lesions were stained immunohistochemically with anti-tyrosinase, A103, S-100, and HMB45. They were scored semiquantitatively for the distribution and intensity of staining. Results —All melanomas, with the exception of desmoplastic melanoma, showed some staining with all four antibodies. Overall, T311 and A103 showed an intermediate sensitivity compared with that of S-100 and HMB45. T311 stained most benign and malignant lesions strongly and diffusely with minimal background staining. Immunoreactivity was found to be patchy in some naevi, with weak or absent staining of the mature melanocytes. A103 showed strong and diffuse staining of all benign lesions and most melanomas with minimal background staining. S-100 was the most sensitive, with diffuse staining of most lesions, including desmoplastic and metastatic melanoma, but lacked specificity. HMB45 was the least sensitive antibody, frequently demonstrating patchy staining with absent staining in some benign naevi. Conclusions —S-100 remains the most sensitive marker of melanocytes. However, because of its lack of specificity, it should be used with at least one other more specific antibody. HMB45 is more specific, but lacks sensitivity; T311 is a reliable marker of melanocytes in paraffin wax embedded sections and is worth consideration for use in a staining panel, although it shows no additional benefit over A103.Keywords
This publication has 22 references indexed in Scilit:
- Molecular Staging of Malignant MelanomaJAMA, 1998
- A103American Journal of Surgical Pathology, 1998
- Comparison of immunohistochemical staining of the novel antibody melan‐A with S100 protein and HMB‐45 in malignant melanoma and melanoma variantsHistopathology, 1998
- Desmoplastic and Spindle-cell Malignant MelanomaAmerican Journal of Surgical Pathology, 1996
- Peripheral Blood Tyrosinase Messenger RNA Detection and Survival in Malignant MelanomaJNCI: Journal of the National Cancer Institute, 1996
- HMB-45 Staining in Benign and Malignant Melanocytic LesionsThe American Journal of Dermatopathology, 1991
- HMB‐45 recognizes stimulated melanocytesJournal of Cutaneous Pathology, 1989
- Nevus Cell Maturation or Atrophy?The American Journal of Dermatopathology, 1988
- New Sites of Human S-100 Immunoreactivity Detected with Monoclonal AntibodiesAmerican Journal of Clinical Pathology, 1986
- Immunohistochemical study on the distribution of α and β subunits of S-100 protein in human neoplasm and normal tissuesVirchows Archiv B Cell Pathology Including Molecular Pathology, 1984